B. Runnebaum

No ORCID on file · 30 papers in corpus
article 1989
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem-68-6-1167

We studied the pharmacokinetics of iv and intranasally administered buserelin, a LHRH agonist peptide, in 14 women with endometriosis. Serum and urinary buserelin concentrations were determined by specific RIA (buserelin antiserum AS-639). …

book-chapter 1989
·doi:10.1007/978-3-642-74784-7_482
article 1989
Archives of gynecology and obstetrics ·doi:10.1007/bf02417628

In a randomized study, the effect of gestrinone (2 x 2.5 mg/week) was compared with the effect of danazol (3 x 200 mg/day) in treating 30 patients with laparoscopically proven endometriotic implants for 6 months. Therapy was effective in 80…

article 1984

In vivo, a single dose of 1000 mg danazol was given orally to pregnant volunteers (n = 8) prior to a therapeutic abortion (8th-12th week of gestation). Changes in serum progesterone and estradiol were evaluated both by analysis of percentag…

article 1983
·doi:10.1016/s0015-0282(16)47295-x

In vitro, danazol showed a slight dose-dependent inhibition of the mitochondrial cholesterol side chain cleavage enzyme isolated from early gestational (8th to 12th week of gestation) placenta. In the presence of 100 microM danazol, the enz…